LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)
Hong Kong · Delayed Price · Currency is HKD 11.92
+0.21 (1.79%)
Jul 31, 2026, 4:08 PM HKT
HKG:2291 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 239.73 | 245.56 | 151.38 | -19.81 | 58.7 |
Depreciation & Amortization | 35.79 | 6.64 | 6.01 | 14.87 | 9.81 |
Asset Writedown & Restructuring Costs | - | - | - | 0 | 0 |
Loss (Gain) From Sale of Investments | - | - | - | 10.66 | -0.53 |
Stock-Based Compensation | - | - | - | 20.51 | 17.8 |
Other Operating Activities | -54.42 | -29.71 | 6.87 | 88.04 | 5.67 |
Change in Accounts Receivable | - | - | - | -12.03 | 13.51 |
Change in Inventory | - | - | - | -24 | -10.08 |
Change in Accounts Payable | - | - | - | 7.92 | 9.25 |
Change in Unearned Revenue | - | - | - | -1.66 | -0.56 |
Change in Other Net Operating Assets | - | - | - | -18.96 | 1.73 |
Operating Cash Flow | 221.1 | 222.49 | 164.26 | 65.53 | 105.28 |
Operating Cash Flow Growth | -0.63% | 35.45% | 150.66% | -37.75% | 78.14% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -76.44 | -85.44 | -97.51 | -13.28 | -22.45 |
Sale of Property, Plant & Equipment | - | 0 | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | -70.08 | -69.39 |
Investment in Securities | 100 | -40.65 | 198.06 | -252.64 | 6.67 |
Other Investing Activities | 5.17 | 8.87 | 10.76 | -70 | - |
Investing Cash Flow | 28.73 | -117.22 | 111.32 | -406 | -85.17 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | -3.63 | -2.38 |
Net Debt Issued (Repaid) | - | - | - | -3.63 | -2.38 |
Issuance of Common Stock | - | - | - | 601.63 | 661.02 |
Common Dividends Paid | -214.98 | -194.77 | - | - | -320 |
Other Financing Activities | -1.57 | -2.14 | -2.05 | -20.2 | 333.58 |
Financing Cash Flow | -216.55 | -196.91 | -2.05 | 577.8 | 672.23 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -3.28 | 0.94 | -6.01 | -6.3 | 2.36 |
Net Cash Flow | 29.99 | -90.7 | 267.52 | 231.04 | 694.69 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 144.66 | 137.05 | 66.75 | 52.25 | 82.83 |
Free Cash Flow Growth | 5.55% | 105.32% | 27.75% | -36.92% | 46.41% |
Free Cash Flow Margin | 27.40% | 29.06% | 20.44% | 21.10% | 37.21% |
Free Cash Flow Per Share | 0.42 | 0.40 | 0.19 | 0.16 | 0.27 |
Levered Free Cash Flow | 37.65 | 82.24 | -6.58 | -707.51 | 646 |
Unlevered Free Cash Flow | 37.72 | 82.35 | -6.49 | -695.65 | 653.22 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 97.79 | 81.73 | 61.27 | 4.72 | 0.52 |
Change in Working Capital | - | - | - | -48.73 | 13.84 |